fda tirzepatide obesity approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with - Eli Lilly FDA approves tirzepatide (Zepbound) injection

10.3389/fcimb.2023.1267721 Front

[DOI] [PubMed] [Google Scholar] 84.Kushner R.F., Ryan D.H., Deanfield J., Kokkinos A., Cercato C., Wilding J., Burguera B., Wu C.C., Craciun A.E., Pall D., et al

doi: 10.1038/s41580-023-00689-6

Certain medications should not be taken with sulfonamides due to potential drug interactions

In an additional 30-week placebo-controlled study of patients with type 2 diabetes inadequately controlled with metformin comparing the maintenance of sitagliptin 100 mg versus withdrawal of sitagliptin when initiating basal insulin therapy, the event rate and incidence of documented symptomatic hypoglycemia (blood glucose measurement 70 mg/dL) did not differ between the sitagliptin and placebo groups

In theory, a mechanism that pushes energy expenditure and lipolysis could shift body composition toward fat loss